Have your own idea? Try our Stock Screener
Over the last 7 days, the Biotech industry has dropped 1.5%, driven by a pullback from CSL of 1.1%. In contrast, Mesoblast has gained 6.7%. Over the last year, the industry has been flat overall. Looking forward, earnings are forecast to grow by 15% annually.
Has the Australian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 24 Jan 2025 | AU$146.8b | AU$24.5b | AU$3.7b | 23.8x | 40x | 6x |
Sun, 22 Dec 2024 | AU$148.5b | AU$24.6b | AU$3.7b | 24.1x | 40.4x | 6x |
Tue, 19 Nov 2024 | AU$145.0b | AU$23.8b | AU$3.5b | 25.6x | 40.9x | 6.1x |
Thu, 17 Oct 2024 | AU$157.6b | AU$23.1b | AU$3.4b | 28.2x | 46.1x | 6.8x |
Sat, 14 Sep 2024 | AU$156.6b | AU$23.0b | AU$3.4b | 29.4x | 46x | 6.8x |
Mon, 12 Aug 2024 | AU$159.6b | AU$22.4b | AU$3.3b | 31.5x | 48.5x | 7.1x |
Wed, 10 Jul 2024 | AU$153.8b | AU$21.9b | AU$3.2b | 31.8x | 48x | 7x |
Fri, 07 Jun 2024 | AU$150.9b | AU$22.2b | AU$3.3b | 31.2x | 46.4x | 6.8x |
Sun, 05 May 2024 | AU$143.1b | AU$22.2b | AU$3.3b | 30.2x | 44x | 6.4x |
Tue, 02 Apr 2024 | AU$147.5b | AU$22.5b | AU$3.3b | 30.3x | 44.7x | 6.5x |
Thu, 29 Feb 2024 | AU$145.6b | AU$22.6b | AU$3.4b | 29.9x | 43.4x | 6.5x |
Sat, 27 Jan 2024 | AU$149.0b | AU$20.8b | AU$2.8b | 34.1x | 53.9x | 7.1x |
Mon, 25 Dec 2023 | AU$143.3b | AU$20.2b | AU$2.7b | 34.3x | 53.8x | 7.1x |
Wed, 22 Nov 2023 | AU$130.7b | AU$20.9b | AU$2.8b | 32x | 47x | 6.3x |
Fri, 20 Oct 2023 | AU$120.1b | AU$21.7b | AU$2.9b | 29.3x | 41.3x | 5.5x |
Sun, 17 Sep 2023 | AU$137.1b | AU$21.4b | AU$2.8b | 32.1x | 49x | 6.4x |
Tue, 15 Aug 2023 | AU$134.8b | AU$18.5b | AU$2.4b | 37.7x | 56.2x | 7.3x |
Thu, 13 Jul 2023 | AU$135.8b | AU$18.0b | AU$2.3b | 36.5x | 58.5x | 7.6x |
Sat, 10 Jun 2023 | AU$155.9b | AU$17.9b | AU$2.3b | 40.9x | 67.4x | 8.7x |
Mon, 08 May 2023 | AU$154.3b | AU$17.8b | AU$2.3b | 41.4x | 67.3x | 8.7x |
Wed, 05 Apr 2023 | AU$148.5b | AU$17.8b | AU$2.3b | 40.2x | 64.9x | 8.3x |
Fri, 03 Mar 2023 | AU$148.9b | AU$17.8b | AU$2.3b | 41.1x | 64.9x | 8.4x |
Sun, 29 Jan 2023 | AU$150.7b | AU$15.2b | AU$2.4b | 55.5x | 63.1x | 9.9x |
Tue, 27 Dec 2022 | AU$147.5b | AU$16.0b | AU$2.6b | 46.2x | 57.8x | 9.2x |
Thu, 24 Nov 2022 | AU$152.2b | AU$16.2b | AU$2.6b | 43x | 58.8x | 9.4x |
Sat, 22 Oct 2022 | AU$137.0b | AU$17.0b | AU$2.7b | 39.3x | 50.2x | 8.1x |
Mon, 19 Sep 2022 | AU$145.8b | AU$16.0b | AU$2.6b | 45.8x | 56.9x | 9.1x |
Wed, 17 Aug 2022 | AU$151.2b | AU$15.3b | AU$2.8b | 42.1x | 54.9x | 9.9x |
Fri, 15 Jul 2022 | AU$149.9b | AU$15.9b | AU$2.9b | 38.4x | 52.2x | 9.4x |
Sun, 12 Jun 2022 | AU$136.7b | AU$15.3b | AU$2.8b | 34.4x | 49.5x | 8.9x |
Tue, 10 May 2022 | AU$136.4b | AU$15.1b | AU$2.8b | 35.4x | 49.4x | 9x |
Thu, 07 Apr 2022 | AU$136.3b | AU$14.1b | AU$2.6b | 39.8x | 53.4x | 9.6x |
Sat, 05 Mar 2022 | AU$132.0b | AU$14.7b | AU$2.7b | 40.1x | 49.5x | 9x |
Mon, 31 Jan 2022 | AU$133.0b | AU$15.0b | AU$2.9b | 36.3x | 46.5x | 8.9x |
46.5x
Which industries have driven the changes within the Australian Healthcare industry?
AU Market | 0.65% | |
Healthcare | 0.09% | |
Biotech | -1.53% | |
Biotech | -1.53% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
MSB Mesoblast | AU$2.87 | 6.7% +AU$490.2m | 983.0% | PS386.2x | |
TLX Telix Pharmaceuticals | AU$27.53 | 3.5% +AU$314.6m | 143.6% | PE187.4x | |
OPT Opthea | AU$0.97 | 18.9% +AU$190.8m | 99.0% | PS2881.5x | |
OCC Orthocell | AU$1.59 | 16.1% +AU$52.6m | 292.6% | PS71.6x | |
ARX Aroa Biosurgery | AU$0.78 | 6.1% +AU$15.5m | 6.8% | PS3.9x |